1,434 results on '"Chiò, Adriano"'
Search Results
2. iDPP@CLEF 2024: The Intelligent Disease Progression Prediction Challenge
3. High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis
4. Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries
5. From use of omics to systems biology: Identifying therapeutic targets for amyotrophic lateral sclerosis
6. Amyotrophic lateral sclerosis: translating genetic discoveries into therapies
7. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
8. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias
9. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
10. Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2023
11. Dealing with Data Scarcity in Rare Diseases: Dynamic Bayesian Networks and Transfer Learning to Develop Prognostic Models of Amyotrophic Lateral Sclerosis
12. iDPP@CLEF 2023: The Intelligent Disease Progression Prediction Challenge
13. Conceptual design of a biped-wheeled wearable machine for ALS patients
14. Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study
15. Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis
16. Factors predicting disease progression in C9ORF72 ALS patients
17. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
18. Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review
19. The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases
20. AIM in Amyotrophic Lateral Sclerosis
21. Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2022
22. Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis
23. C9orf72 ALS mutation carriers show extensive cortical and subcortical damage compared to matched wild-type ALS patients
24. Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression
25. Dietary habits, nutritional status and risk of a first demyelinating event: an incident case-control study in a southern European cohort
26. Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes
27. Percutaneous gastrostomy, mechanical ventilation and survival in amyotrophic lateral sclerosis : an observational study in an incident cohort
28. Use of the combination of spirometry, arterial blood gas analysis and overnight oximetry to predict the outcomes of patients affected by motor neuron disease: The Milan‐Torin respiratory score (Mi‐To‐RS)
29. High Frequency of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis Patients with SOD1 Pathogenic Variants
30. Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis
31. Hereditary motor sensory neuropathy with proximal involvement (HMSN‐P) associated with TFG p.Pro285Leu variant in an Italian family with a motor neuron disease‐like clinical picture
32. Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers
33. European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD)
34. Deep learning methods to predict amyotrophic lateral sclerosis disease progression
35. Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial
36. Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis
37. G507D mutation in FUS gene causes familial amyotrophic lateral sclerosis with a specific genotype-phenotype correlation
38. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study
39. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis
40. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
41. Causal associations of genetic factors with clinical progression in amyotrophic lateral sclerosis
42. Camillo Negro
43. Calculated Maximal Volume Ventilation (cMVV) as a Marker of Early Respiratory Failure in Amyotrophic Lateral Sclerosis (ALS)
44. Feasibility assessment of using the MiToS staging system for conducting economic evaluation in amyotrophic lateral sclerosis
45. Resting‐state fMRI functional connectome of C9orf72 mutation status
46. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
47. The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis
48. The links between diabetes mellitus and amyotrophic lateral sclerosis
49. Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study
50. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.